Updated on 10 April 2014
Q: What kind of R&D will be carried at BGRC?
Dr Schabacker: Syngene's Baxter-dedicated global research center will conduct product and analytical development of parental nutrition and renal therapy solutions in the Baxter portfolio. As this partnership evolves, we will continue to look for innovative models of product development and support that meet both global and local needs.
Q: What are your expectations from Syngene and vice-versa?
Dr Schabacker: The Baxter-Syngene partnership has started off very well, and there is potential to grow and evolve this partnership into more product and scientific areas. We believe there is great availability of world class talent in India, and this talent pool will augment and increase the productivity of Baxter's global R&D.